Nuclear receptor signalling in dendritic cells connects lipids, the genome and immune function

被引:68
作者
Szatmari, Istvan [2 ]
Nagy, Laszlo [1 ,2 ]
机构
[1] Univ Debrecen, Med & Hlth Sci Ctr, Hungarian Acad Sci,Res Ctr Mol Med, Dept Biochem & Mol Biol,Apoptosis & Genom Res Grp, H-4010 Debrecen, Hungary
[2] Univ Debrecen, Med & Hlth Sci Ctr, Dept Biochem & Mol Biol, Debrecen, Hungary
基金
英国惠康基金; 匈牙利科学研究基金会;
关键词
dendritic cells; immunity; lipid signalling; nuclear receptors; PPAR gamma;
D O I
10.1038/emboj.2008.160
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dendritic cells (DCs) are sentinels of the immune system and represent a heterogeneous cell population. The existence of distinct DC subsets is due to their inherent plasticity and to the changing microenvironment modulating their immunological properties. Numerous signalling pathways have impacts on DCs. It appears that besides cytokines/chemokines, lipid mediators also have profound effects on the immunogenicity of DCs. Some of these lipid mediators exert an effect through nuclear hormone receptors. Interestingly, more recent findings suggest that DCs are able to convert precursors to active hormones, ligands for nuclear receptors. Some of these DC-derived lipids, in particular retinoic acid (RA), have a central function in shaping T-cell development and effector functions. In this review, we summarize and highlight the function of a set of nuclear receptors (PPAR gamma, RA receptor, vitamin D receptor and glucocorticoid receptor) in DC biology. Defining the contribution of nuclear hormone receptor signalling in DCs can help one to understand the regulatory logic of lipid signalling and allow the exploitation of their potential for therapeutic intervention in various immunological diseases.
引用
收藏
页码:2353 / 2362
页数:10
相关论文
共 85 条
[1]   Influence of immunosuppressive drugs on dendritic cells [J].
Abe, M ;
Thomson, AW .
TRANSPLANT IMMUNOLOGY, 2003, 11 (3-4) :357-365
[2]   Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization [J].
Angeli, V ;
Llodrá, J ;
Rong, JX ;
Satoh, K ;
Ishii, S ;
Shimizu, T ;
Fisher, EA ;
Randolph, GJ .
IMMUNITY, 2004, 21 (04) :561-574
[3]   Peroxisome proliferator-activated receptor γ inhibits the migration of dendritic cells:: Consequences for the immune response [J].
Angeli, W ;
Hammad, H ;
Staels, B ;
Capron, M ;
Lambrecht, BN ;
Trottein, F .
JOURNAL OF IMMUNOLOGY, 2003, 170 (10) :5295-5301
[4]   PPAR-γ agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-κB pathways [J].
Appel, S ;
Mirakaj, V ;
Bringmann, A ;
Weck, MM ;
Grünebach, F ;
Brossart, P .
BLOOD, 2005, 106 (12) :3888-3894
[5]   Dendritic cells and the control of immunity [J].
Banchereau, J ;
Steinman, RM .
NATURE, 1998, 392 (6673) :245-252
[6]   PPARδ:: a dagger in the heart of the metabolic syndrome [J].
Barish, GD ;
Narkar, VA ;
Evans, RM .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (03) :590-597
[7]  
BEDFORD PA, 1989, CLIN EXP IMMUNOL, V75, P481
[8]   All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation [J].
Benson, Micah J. ;
Pino-Lagos, Karina ;
Rosemblatt, Mario ;
Noelle, Randolph J. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (08) :1765-1774
[9]  
BOBRYSHEV YV, 1995, CARDIOVASC RES, V29, P689, DOI 10.1016/0008-6363(96)88642-1
[10]   CD1: Antigen presentation and T cell function [J].
Brigl, M ;
Brenner, MB .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :817-890